Stockreport

Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer [Investor's Business Daily]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF Related news 9:23 AM ET Biotech giant Amgen could be nearing a deal to buy Alexion Pharmaceuticals at a 74% premium, according to a Spanish... Should You Buy Pharma G [Read more]